South Coast Clinical Trials Leads the Industry in Patient Informed Consent Process Standards

Dec. 29, 2009 - PRLog -- ANAHEIM, Calif. - The patient informed consent process is the core of clinical research industry ethics and South Coast Clinical Trials is committed to ensuring that their procedures exceed the industry standards for both informed consent and patient care.

“Informed consent is the core ethical standard for everything we do at South Coast Clinical Trials,” said Dr. Adonis Sfera, MD, founder of South Coast Clinical Trials. “We take the minimum standards for the industry and proudly exceed them with strong informed consent processes and compassionate patient care before, during and after the trial. By doing this, we are ensuring the patient, their family and their caregivers are aware of all potential risks and benefits of joining a particular study.”

The core of the informed consent process is disclosing to patients important elements of the clinical trial such as the research objective; research procedures; the risks and benefits; alternatives; confidentiality policies; disclosure of any conflicts of interest and the right to withdraw from clinical studies.

“We make sure that patients and their families can clearly understand the information by explaining it to them in easy to understand language that avoids all the confusing medical terminology,” Dr. Sfera said. “We have high disclosure standards so that our patients can actually benefit from their participation in the clinical trial process.”

South Coast Clinical Trials not only exceeds the industry guidelines for patient safety and care, but also backs it up with a dedicated group of follow-up care professionals that includes case managers, social workers, support groups, day treatment centers, and group homes that are able to help patients transition from clinical trials treatments to ongoing care.

“We select patients for our clinical trials after providing all of the information up front and giving them the opportunity to discuss options with trusted family and friends,” Dr. Sfera said. “We also give them the best follow-up care we can to make sure that they receive the best care they can to treat their affliction.”

For more information on South Coast Clinical Trials, or to get information about the firm conducting a clinical trial for your firm, please visit them on the Internet at www.southcoastclinicaltrials.com.

About South Coast Clinical Trials

South Coast Clinical Trials, Inc is a dedicated Southern California research facility founded in 2001 by Dr. Adonis Sfera, MD that specializes in psychiatric and neurological clinical trials.

We are dedicated to assisting in the process of developing and implementing new study drugs to the marketplace, while maintaining participant safety and satisfaction exceeding the industry standard. We specialize in central nervous system disorders, which include Schizophrenia, Bipolar Disorder, Major Depression, and Alzheimer’s Disease etc.

To date, we have worked with various sponsors including AstraZeneca, Pfizer, Merck, Solvay, Johnson & Johnson, Quintiles, Kendle, Myriad, PPD, PRA, DSP, Takeda, UBC, Wyeth, and Novartis, among others.

For more information about South Coast Clinical Trials, please visit us on the Internet at http://www.southcoastclinicaltrials.com.

-30-

# # #

EquityPR is the nation's leading affordable press release writing and distribution company with $98 custom press release writing with distribution to a firm's local market. Visit us at www.equitypr.com.